Cargando…

New Insights into Pathogenesis and Treatment of ANCA-Associated Vasculitis: Autoantibodies and Beyond

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is a group of rare systemic diseases affecting small-caliber vessels. The damage caused by AAV mainly involves the lung and kidneys. AAV includes three different types: granulomatosis with polyangiitis (GPA), microscopic polyangiitis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paroli, Marino, Gioia, Chiara, Accapezzato, Daniele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045085/ https://www.ncbi.nlm.nih.gov/pubmed/36975372 http://dx.doi.org/10.3390/antib12010025

Ejemplares similares

Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus
por: Accapezzato, Daniele, et al.
Publicado: (2023)

Janus Kinase Inhibitors: A New Tool for the Treatment of Axial Spondyloarthritis
por: Paroli, Marino, et al.
Publicado: (2023)

Recent advances in understanding of the pathogenesis of ANCA-associated vasculitis
por: Prendecki, Maria, et al.
Publicado: (2018)

Antineutrophil cytoplasmic antibodies (ANCA) – their role in pathogenesis, diagnosis, and treatment monitoring of ANCA-associated vasculitis
por: FIJOŁEK, JUSTYNA, et al.
Publicado: (2020)

Hepatitis C virus infection and autoimmune diseases
por: Paroli, Marino, et al.
Publicado: (2012)

Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis
por: Simon, Amélie, et al.
Publicado: (2016)

Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated Vasculitis
por: Mescia, Federica, et al.
Publicado: (2023)

Progress in treatment of ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2012)

The contribution of genetic variation and infection to the pathogenesis of ANCA-associated systemic vasculitis
por: Willcocks, Lisa C, et al.
Publicado: (2010)

The kidneys and ANCA-associated vasculitis: from pathogenesis to diagnosis
por: Rowaiye, Olumide Olatubosun, et al.
Publicado: (2015)

Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody（ANCA）-associated vasculitis
por: Tsukui, Daisuke, et al.
Publicado: (2021)

The immunopathology of ANCA-associated vasculitis
por: McKinney, Eoin F., et al.
Publicado: (2014)

Immunopathogenesis of ANCA-Associated Vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

ANCA-Associated Vasculitis: An Update
por: Almaani, Salem, et al.
Publicado: (2021)

New Insights Into Novel Therapeutic Targets in ANCA-Associated Vasculitis
por: Nozaki, Yuji
Publicado: (2021)

Churg—Strauss syndrome associated with antiphospholipid antibodies in a patient with recurrent myocardial and cerebral ischemia
por: Paroli, Marino, et al.
Publicado: (2012)

ANCA Associated Vasculitis Subtypes: Recent Insights and Future Perspectives
por: Austin, Keziah, et al.
Publicado: (2022)

Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesis
por: Jin, Qiuyu, et al.
Publicado: (2018)

ANCA associated vasculitis
por: Hunter, Robert W, et al.
Publicado: (2020)

Granulomatous Inflammation in ANCA-Associated Vasculitis
por: Müller, Antje, et al.
Publicado: (2021)

Clinical use of biologics in vasculitis syndromes
por: Paroli, Marino
Publicado: (2012)

Mechanisms of thrombosis in ANCA-associated vasculitis
por: Misra, Durga Prasanna, et al.
Publicado: (2021)

Interstitial Lung Disease with ANCA-associated Vasculitis
por: Katsumata, Yasuhiro, et al.
Publicado: (2015)

ANCA-associated vasculitis in childhood: recent advances
por: Calatroni, Marta, et al.
Publicado: (2017)

Therapy of ocular complications in ANCA+ associated vasculitis
por: Macarie, Sorin Simion, et al.
Publicado: (2021)

B Lineage Cells in ANCA-Associated Vasculitis
por: Merino-Vico, Ana, et al.
Publicado: (2021)

ANCA-associated vasculitis of the appendix
por: Leaver, Phillip J, et al.
Publicado: (2019)

Comorbidities in ANCA-associated vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

Daratumumab for the treatment of refractory ANCA-associated vasculitis
por: Ostendorf, Lennard, et al.
Publicado: (2023)

Antineutrophil Cytoplasmic Autoantibody (ANCA)-Associated Vasculitis With Mucosal Involvement Following COVID-19 Pneumonia
por: Ta, Hoang, et al.
Publicado: (2022)

The Nasal Microbiome in ANCA-Associated Vasculitis: Picking the Nose for Clues on Disease Pathogenesis
por: Dekkema, G. J., et al.
Publicado: (2021)

Eye involvement in ANCA positive vasculitis
por: Macarie, Sorin Simion, et al.
Publicado: (2020)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
por: Wallace, Zachary S., et al.
Publicado: (2019)

Automated interpretation of ANCA patterns - a new approach in the serology of ANCA-associated vasculitis
por: Knütter, Ilka, et al.
Publicado: (2012)

ANCA-associated vasculitis after COVID-19
por: Izci Duran, Tugba, et al.
Publicado: (2021)

Autoantibodies in vasculitis
por: Wiik, Allan
Publicado: (2003)

Type of ANCA May Be Indispensable in Distinguishing Subphenotypes of Different Clinical Entities in ANCA-Associated Vasculitis
por: Konstantouli, Afroditi Maria, et al.
Publicado: (2022)

Animal Models of ANCA Associated Vasculitis
por: Shochet, Lani, et al.
Publicado: (2020)

Complement Inhibition in ANCA-Associated Vasculitis
por: Tesar, Vladimir, et al.
Publicado: (2022)

The involvement of NETs in ANCA-associated vasculitis
por: Shiratori-Aso, Satoka, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jkabr39jl4q6tq0m5g1b50jm0h